Michael Burton

Michael Burton is currently the Vice President of Value Creation at Jumo Health, a position held since January 2025. Prior to this role, Burton served as an Advisor to the CEO at Katalyze AI, an AI-based optimization platform for biomanufacturing, and as an Expert at Del Mar Advisory Group, specializing in SaaS and value sales. Additional advisory roles include working with Alpha Studio, a venture studio focused on AI projects. Burton held various positions in digital health and value engineering at PACT and Tendo, respectively, as well as leadership roles at Veeva Systems and Theorem Clinical Research. An early career at Wyeth and ICON Clinical Research provided a strong foundation in clinical trial management and research. Burton holds a B.S. in Animal Bioscience from Penn State University, achieved in 1995.